Intrinsic Value of S&P & Nasdaq Contact Us

ICON Public Limited Company ICLR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • IE • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
$217.20
+92.1%
Analyst Price Target
$157.44
+39.3%

ICON Public Limited Company (ICLR) — Analyst outlook / Analyst consensus target is. Based on 30 analyst ratings, the consensus is bullish — 17 Buy, 12 Hold, 1 Sell.

The consensus price target is $157.44 (low: $100.00, high: $222.00), representing an upside of 39.3% from the current price $113.06.

Analysts estimate Earnings Per Share (EPS) of $13.99 and revenue of $8.28B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $9.60 vs est $13.99 (missed -31.4%). Analyst accuracy: 54%.

ICLR Stock — 12-Month Price Forecast

$157.44
▲ +39.25% Upside
Average Price Target
Based on 30 Wall Street analysts offering 12-month price targets for ICON Public Limited Company, the average price target is $157.44, with a high forecast of $222.00, and a low forecast of $100.00.
The average price target represents a +39.25% change from the last price of $113.06.
Highest Price Target
$222.00
Average Price Target
$157.44
Lowest Price Target
$100.00

ICLR Analyst Ratings

Buy
30
Ratings
17 Buy
12 Hold
1 Sell
Based on 30 analysts giving stock ratings to ICON Public Limited Company in the past 3 months
Rating breakdown
Buy
17 57%
Hold
12 40%
Sell
1 3%
57%
Buy
17 analysts
40%
Hold
12 analysts
3%
Sell
1 analysts

EPS Estimates — ICLR

54%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $9.60 vs Est $13.99 ▼ 45.7% off
Profitability Outlook
Strong profitability with high earnings per share. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — ICLR

100%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $8.282B vs Est $8.279B ▲ 0.0% off
Revenue Trend
Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message